Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nicola Silvestris Viviana Bazan Daniele Santini Daniele Fanale Gaspare Gulotta |
| Publication date | November 1, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |